Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 57 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
561 16.8 months Malignant pleural mesothelioma 4 Chemotherapy
Radiation
Surgery
Memorial Sloan-Kettering Cancer Center United States 6/2009
Treatment Details: Patients: This phase 2 study involved 77 patients with stage I, II, or III malignant pleural mesothelioma. The median age was 63, ranging from 34 to 78 years of age. There were 56 men and
 
562 16.8 months recurrent ovarian cancer 4 Chemotherapy
Hospital Universitario Ramon y Cajal Spain 5/2005
Treatment Details: Patients: This Phase II study involved 78 women with recurrent platinum-sensitive ovarian cancer. The patients were randomized into two groups. The median age for Group A (40 women) was 61
 
563 16.8 months Metastatic breast cancer 5 Chemotherapy
Medical Center Alkmaar Netherlands 3/2014
Treatment Details: Patients: This phase 3 study involved elderly (65 years or older) female metastatic breast cancer patients who were divided into two different treatment groups. Group A consisted of 40 pat
 
564 16.8 months HER2-negative advanced breast cancer 5 Biologic therapy
Chemotherapy
Northwestern University Feinberg School of Medicine United States 1/2013
Treatment Details: Patients: This phase 2 study involved female HER2-negative advanced breast cancer patients who were divided into two separate treatment groups. Group A had 119 patients with an average age
 
565 16.8 months Metastatic breast cancer 4 Chemotherapy
University Hospitalof Heraklion Greece 5/2012
Treatment Details: Patients: This phase 2 study involved 30 women with metastatic breast cancer who had previously received chemotherapy. The median patient age was 57.5 years. Treatment: Patients were t
 
566 16.8 months Metastatic Melanoma 4 Biologic therapy
Chemotherapy
St. Mary's Medical Center United States 2/2015
Treatment Details: Patients: This phase 2 study involved 50 metastatic melanoma patients who had not received prior chemotherapy. The median patient age was 62 years and 64% were male. Treatment: Patient
 
567 16.7 months Hormone-refractory prostate cancer 4 Hormone
University of California San Francisco United States 9/2004
Treatment Details: Patients: This Phase III trial involved a total of 260 patients with hormone refractory (androgen independent) prostate cancer. Patients were divided into two groups: Group 1 with 132 patie
 
568 16.7 months Hormone-refractory prostate cancer 3 Chemotherapy
Taussig Cancer Center, The Cleveland Clinic Foundation United States 1/2005
Treatment Details: Patients: This Phase II study involved 39 patients with hormone refractory prostate cancer. The median age was 69 years and the median PSA was 117.7 (range 4.3 1497.8). Thirty-three pati
 
569 16.6 months Advanced colorectal cancer 4 Chemotherapy
Ottawa Hospital Regional Cancer Centre Canada 12/2005
Treatment Details: Patients: This Phase I/II study involved 31 patients with metastatic colorectal cancer. Twenty-one patients were men, ten were women, and the median age was 60 years. Metastatic sites incl
 
570 16.6 months Advanced colorectal cancer 4 Chemotherapy
Ottawa Hospital Regional Cancer Centre Canada 12/2005
Treatment Details: Patients: This Phase I/II study involved 31 patients with metastatic colorectal cancer. Twenty-one patients were men, ten were women, and the median age was 60 years. Metastatic sites incl
 
Page 57 of 187  | Previous Page  | Next Page